EE+ POEM Archive
Nirsevimab reduces the risk of a medically attended visit for respiratory syncytial virus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Nirsevimab Reduces the Risk of a Medically Attended Visit for Respiratory Syncytial Virus." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315625/all/Nirsevimab_reduces_the_risk_of_a_medically_attended_visit_for_respiratory_syncytial_virus.
Nirsevimab reduces the risk of a medically attended visit for respiratory syncytial virus. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315625/all/Nirsevimab_reduces_the_risk_of_a_medically_attended_visit_for_respiratory_syncytial_virus. Accessed April 26, 2024.
Nirsevimab reduces the risk of a medically attended visit for respiratory syncytial virus. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315625/all/Nirsevimab_reduces_the_risk_of_a_medically_attended_visit_for_respiratory_syncytial_virus
Nirsevimab Reduces the Risk of a Medically Attended Visit for Respiratory Syncytial Virus [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 April 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315625/all/Nirsevimab_reduces_the_risk_of_a_medically_attended_visit_for_respiratory_syncytial_virus.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Nirsevimab reduces the risk of a medically attended visit for respiratory syncytial virus
ID - 1315625
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315625/all/Nirsevimab_reduces_the_risk_of_a_medically_attended_visit_for_respiratory_syncytial_virus
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
